These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 10496654

  • 1. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.
    Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Höltje HD, Korting HC.
    Pharm Res; 1999 Sep; 16(9):1386-91. PubMed ID: 10496654
    [Abstract] [Full Text] [Related]

  • 2. Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.
    Gysler A, Lange K, Korting HC, Schäfer-Korting M.
    Pharm Res; 1997 Jun; 14(6):793-7. PubMed ID: 9210199
    [Abstract] [Full Text] [Related]

  • 3. Solid lipid nanoparticles as drug carriers for topical glucocorticoids.
    Maia CS, Mehnert W, Schäfer-Korting M.
    Int J Pharm; 2000 Mar 10; 196(2):165-7. PubMed ID: 10699710
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids.
    Lange K, Kleuser B, Gysler A, Bader M, Maia C, Scheidereit C, Korting HC, Schäfer-Korting M.
    Skin Pharmacol Appl Skin Physiol; 2000 Mar 10; 13(2):93-103. PubMed ID: 10754457
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies on the pharmacokinetics and metabolism of prednicarbate after cutaneous and oral administration.
    Barth J, Lehr KH, Derendorf H, Möllmann HW, Höhler T, Hochhaus G.
    Skin Pharmacol; 1993 Mar 10; 6(3):179-86. PubMed ID: 8274287
    [Abstract] [Full Text] [Related]

  • 12. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M, Korting HC, Kerscher MJ, Lenhard S.
    Clin Pharmacol Ther; 1993 Oct 10; 54(4):448-56. PubMed ID: 8222488
    [Abstract] [Full Text] [Related]

  • 13. 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.
    Korting HC, Vieluf D, Kerscher M.
    Eur J Clin Pharmacol; 1992 Oct 10; 42(2):159-61. PubMed ID: 1618247
    [Abstract] [Full Text] [Related]

  • 14. In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use.
    Lombardi Borgia S, Schlupp P, Mehnert W, Schäfer-Korting M.
    Eur J Pharm Biopharm; 2008 Feb 10; 68(2):380-9. PubMed ID: 17574402
    [Abstract] [Full Text] [Related]

  • 15. Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.
    Kerscher MJ, Korting HC.
    Acta Derm Venereol; 1992 Feb 10; 72(3):214-6. PubMed ID: 1357864
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro percutaneous absorption of fusidic acid and betamethasone 17-valerate across canine skin.
    Degim IT, Hadgraft J, Houghton E, Teale P.
    J Small Anim Pract; 1999 Nov 10; 40(11):515-8. PubMed ID: 10649594
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effect of medium potent nonhalogenated double-ester-type and conventional glucocorticoids on proliferation and chemotaxis of fibroblasts in vitro.
    Hein R, Korting HC, Mehring T.
    Skin Pharmacol; 1994 Nov 10; 7(5):300-6. PubMed ID: 8054213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.